Skin cancer – RCR consensus statements
Date: 2026
Publication
The RCR consensus process was initially developed in 2016 to help reduce variation in UK radiotherapy practice. The skin cancer consensus statements should serve as a practical stimulus for skin multi-disciplinary cancer teams to review their current radiotherapy service to ensure that they are able to deliver optimal treatment for their patients. They should be adopted in parallel with relevant National Institute for Health and Care Excellence (NICE) guidance.
These areas are covered by the consensus statements:
General Principles
Squamous Cell Carcinoma
Merkel Cell Carcinoma, melanoma and rare tumours
